Inflammation Research Erlangen stands for interdisciplinary inflammation research for the development of innovative, targeted therapies against chronic inflammatory and autoimmune diseases. Together, we want to make our research and our findings more visible. This led to the task of designing…
Campaign launch #BackToHealth
We’re thrilled to share the journey of Janina, one of our very first patients to receive the groundbreaking CAR T-Cell therapy right here in Erlangen. Her story is not just inspiring – it’s a beacon of hope for many! As…
Register now: 16th International Forum of Rheumatoid Arthritis 2024
We are pleased to announce that the 16th International Forum on Rheumatoid Arthritis will take place in Bamberg (Bavaria) from the 17th to the 19th of October 2024! Registration is open now. Register here The theme of this year’s symposium…
Revolutionary autoimmune therapy now also possible for children and teenagers
A strong interdisciplinary collaboration in #CAR T cell therapy treated a now 16-year-old girl received the immunotherapy as part of an individualised treatment trial at UniversitĂ€tsklinikum Erlangen as the first child with Lupus worldwide. Systemic Hashtag#Lupus Erythematosus (#SLE) – a…
1st TRR369 DIONE Retreat at Castle Ettersburg
We are thrilled to share highlights from the first retreat of our consortium, TRR369 DIONE #DFG! Last week, our incredible team of researchers gathered to discuss groundbreaking advancements and the future of our research. Key Highlights: Engaging presentations on cutting-edge…